LIVER FIBROSIS/NASH

Clinical trials for LIVER FIBROSIS/NASH explained in plain language.

Never miss a new study

Get alerted when new LIVER FIBROSIS/NASH trials appear

Sign up with your email to follow new studies for LIVER FIBROSIS/NASH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Common vitamin shows promise against silent liver disease

Disease control Recruiting now

This study is testing whether a common vitamin, niacin (vitamin B3), can help reduce harmful fat buildup in the liver. Researchers will give 36 older adults with fatty liver disease either niacin or a placebo pill for 12-week periods to see if the vitamin helps the body store fat…

Matched conditions: LIVER FIBROSIS/NASH

Phase: NA • Sponsor: Université de Sherbrooke • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

LIVER FIBROSIS/NASH

Get alerted when new LIVER FIBROSIS/NASH trials appear

Common vitamin shows promise against silent liver disease